Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is DexCom Stock Underperforming the S&P 500?

Valued at a market cap of $27.4 billion, DexCom, Inc. (DXCM) operates in the medical devices sector. The California-based company specializes in continuous glucose monitoring systems that provide real-time blood glucose data to aid diabetes management.

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and DexCom fits this criterion perfectly, exceeding the mark. DexCom is renowned for its advanced continuous glucose monitoring systems, including the Dexcom G6 and G7, which provide real-time glucose data and trend insights, transforming diabetes management with over 20,000 users in its Dexcom Warrior community.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.